Integrated Diagnostics Holdings PLC Award from the College of American Pathologists (9004F)
26 February 2018 - 8:49PM
UK Regulatory
TIDMIDHC
RNS Number : 9004F
Integrated Diagnostics Holdings PLC
26 February 2018
26 February 2018
Integrated Diagnostics Holdings' central Mega Lab in Cairo earns
certification from College of American Pathologists
The state of the art facility, operational since mid-2015, is
the only medical diagnostics laboratory in Egypt with CAP
certification
(London) - Integrated Diagnostics Holdings ("IDH"), IDHC on the
London Stock Exchange, a leading consumer healthcare company with
operations in Egypt, Jordan, Sudan and Nigeria, announced today
that the Group has been awarded certification for its Cairo Mega
Lab from the College of American Pathologists (CAP).
The Mega Lab, inaugurated in June 2015, replaced two smaller,
independent "A-labs," one of which was CAP certified.
The College of American Pathologists is the world's largest
association composed exclusively of pathologists certified by the
American Board of Pathology. It is widely considered the leader in
laboratory quality assurance globally. The CAP Laboratory
Accreditation Program accredits the entire spectrum of laboratory
test disciplines with the most scientifically rigorous customised
checklist requirements.
IDH's Mega Lab is the only private laboratory in Egypt to
receive this distinguished certification.
Dr. Hend El Sherbini, CEO, said: "Diagnostic testing is critical
to quality healthcare. We are playing a pivotal role in improving
healthcare outcomes among the resource-poor populations we serve
and know that can only be accomplished by providing the
highest-quality services for the prevention and early detection of
disease. The international accreditation of our facilities
constructs a competitive barrier to entry to our markets and, as
importantly, imparts an assurance of quality and safety that
engenders strong loyalty among our valued corporate as well as
individual customers."
IDH operates an asset-light, scalable "Hub, Spoke and Spike"
business model in which its Mega Lab functions as the central
"Hub." Equipped for all services and tests offered by the Group,
the Mega lab supports a network of 382 branch laboratories across
four countries in the Middle East and Africa. The Mega Lab is very
much a testament to the Company's institutional capacity to realise
its vision to make modern medical diagnostics more accessible to
all of the emerging markets it serves. Building its Mega Lab de
novo in 2015, IDH constructed a state-of-the-art facility with
ample excess capacity in preparation for the rapid expansion it has
successfully been executing in recent years.
This news of the Mega Lab's CAP certification follows the recent
announcement of the Group's investment in Nigeria, which not only
gives the Company a foothold in Africa's largest and most populous
country, but broadens its diagnostic service officering to include
radiology.
IDH will report its financial results for the 2017 year on 21
March 2018.
-ENDS-
Media enquiries
Integrated Diagnostics Holdings
Sherif El-Ghamrawi
Investor Relations Director
T: +20 (0)2 3345 5530 | M: +20 (0)10 0447 8699 |
sherif.elghamrawi@idhcorp.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDMGZZLVGGRZG
(END) Dow Jones Newswires
February 26, 2018 04:49 ET (09:49 GMT)
Integrated Diagnostics (LSE:IDHC)
Historical Stock Chart
From Apr 2024 to May 2024
Integrated Diagnostics (LSE:IDHC)
Historical Stock Chart
From May 2023 to May 2024